Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Period	PE Ratio
2016-12-31	N/A
2017-12-31	N/A
2018-12-31	2563.33
2019-12-31	809.47
2020-12-31	1398.18
2021-12-31	615.20
2022-12-31	2197.14
2023-12-31	51.96
2024-12-31	25.76
2025-12-31	43.82

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PODD	$153.80	-0.69%	1.30M
3
4
5

Insulet Corporation (PODD) PE Ratio

PE Ratio Data

Get Insulet Corporation Data in Excel

More PODD Financial Data